Corvidia Therapeutics Secures $26,000,000 Series A Funding
Company Name Corvidia Therapeutics
Mailing Address 35 Gatehouse Drive Waltham, MA 02451 USA
Company Description Corvidia Therapeutics is a biotechnology company pioneering the next generation of cardiovascular therapies. Leveraging functional genomics, the company’s founding team has decoded previously unrecognized genetic susceptibilities within general cardiovascular populations.